MSD opens expanded Irish medicine plants after €1bn investment

  • 📰 IrishTimes
  • ⏱ Reading Time:
  • 31 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 98%

United States News News

United States United States Latest News,United States United States Headlines

Taoiseach welcomes regional spread of investment as new operations open in Dunboyne and Carlow as company recruits for 100 vacancies

Sanat Chattopadhyay, MSD executive vice-president and president of its manufacturing division, said the expansion was “another new chapter in our long-standing legacy in Ireland”

Carlow was MSD’s first vaccines site outside the US when it was opened in 2008. It now operates as a filling site for both new and existing MSD vaccines, biologics medicines and older generation small molecule drugs. Specialising in providing drug substance for clinical trials and early phase development, it is understood to be the US drug giant’s first such plant outside the US. The latest investment was focused on developing a new research facility next to the biologics manufacturing plant in a move the company says will significantly accelerate the time it takes to bring a medicine to market.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in US
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

United States United States Latest News, United States United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Irish tech companies raise close to €1bn in first half of the yearSmaller firms struggle to raise cash, even as investment levels hit new record
Source: IrishTimes - 🏆 3. / 98 Read more »